EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Non-surgical periodontal therapy and systemic inflammatory biomarkers in patients with periodontitis and carotid plaque burden: a pilot study

Ana Maria Hofer, Andrei Picos, Alexandra Dădârlat-Pop, Raluca Tomoaia, Horia Rosianu, Ilyés Tamás, Monica Popa

Frontiers in Cellular and Infection Microbiology · 21.08.2026 · 16

DOI: 10.3389/fcimb.2026.1881815 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 21.08.2026. Verfasst von Ana Maria Hofer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community Health, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Biomarkers, Periodontitis, Plaque, Atherosclerotic, Inflammation. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Systemic inflammation is a key contributor to the pathophysiology of carotid plaque burden (CpB). Increasing evidence supports a link between periodontitis and systemic conditions, including endothelial dysfunction, and CpB. This study aimed to explore inflammatory mediators involved in cardiovascular disease that may represent shared mechanistic pathways between periodontitis and carotid plaque burden, and to determine whether non-surgical periodontal therapy modulates systemic inflammatory activity.

Methods

A pilot study was conducted on subjects presenting with both periodontitis and CpB. Of 87 initially screened participants, 10 met the inclusion criteria and completed the study. Periodontal parameters—probing pocket depth (PPD), clinical attachment loss (CAL), and bleeding on probing (BOP)—were recorded. Systemic inflammatory biomarkers, including matrix metalloproteinase-8 (MMP-8), myeloperoxidase (MPO), lipoprotein-associated phospholipase A2 (Lp-PLA2), and soluble CD40 ligand (sCD40L), were analyzed.

Results

Participants demonstrated severe periodontal disease, with mean PPD of 5.5 mm (maximum 8 mm), mean CAL of 6.46 mm (maximum 12 mm), and BOP of 67%. Periodontal therapy was associated with significant reductions for MMP-8 (25.64 ± 20.31 vs. 10.60 ± 3.41ng/mL post-treatment; p = 0.010) and Lp-PLA2 (p = 0.0195). MPO and sCD40L showed decreasing trends that did not reach statistical significance (p = 0.097 and p = 0.156, respectively). Correlation analyses demonstrated limited associations between baseline biomarker levels and periodontal clinical parameters, except for an inverse correlation between sCD40L and probing pocket depth (ρ = −0.77, p = 0.015).

Conclusion

Inflammatory biomarkers may represent important mechanistic links between periodontitis and imaging-confirmed carotid atherosclerotic plaques. Within the limitations of this pilot study, non-surgical periodontal therapy was associated with reductions in selected systemic inflammatory biomarkers, supporting the feasibility of investigating the periodontitis–carotid plaque axis in larger translational cohorts. Larger studies are needed to validate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersPeriodontitisPlaque, AtheroscleroticInflammationHumansPilot ProjectsFemaleMaleMiddle AgedMatrix Metalloproteinase 8AgedPeroxidaseCD40 Ligand1-Alkyl-2-acetylglycerophosphocholine Esterase

Stichwörter der Autor:innen

cardiovascular riskcarotid plaque burdeninflammatory biomarkersperiodontitissystemic inflammation

Substanzen

BiomarkersMatrix Metalloproteinase 8PeroxidaseCD40 Ligand1-Alkyl-2-acetylglycerophosphocholine Esterase

Autor:innen und Institutionen

  • Department of Community Health, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Department of Oral Prevention, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Department of Cardiology, Heart Institute "N. Stăncioiu", Cluj-Napoca, Romania.
  • 4th Department of Internal Medicine, Faculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Department of Cardiology, Rehabilitation Hospital, Cluj-Napoca, Romania.
  • Department of Molecular Sciences, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Zitieren

APA

Hofer, A. M., Picos, A., Dădârlat-Pop, A., Tomoaia, R., Rosianu, H., Tamás, I., & Popa, M. (2026). Non-surgical periodontal therapy and systemic inflammatory biomarkers in patients with periodontitis and carotid plaque burden: a pilot study. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1881815

Vancouver

Hofer AM, Picos A, Dădârlat-Pop A, Tomoaia R, Rosianu H, Tamás I, et al. Non-surgical periodontal therapy and systemic inflammatory biomarkers in patients with periodontitis and carotid plaque burden: a pilot study. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1881815

BibTeX
@article{Hofer2026,
  author = {Hofer, Ana Maria and Picos, Andrei and Dădârlat-Pop, Alexandra and Tomoaia, Raluca and Rosianu, Horia and Tamás, Ilyés and Popa, Monica},
  title = {Non-surgical periodontal therapy and systemic inflammatory biomarkers in patients with periodontitis and carotid plaque burden: a pilot study},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1881815}
}
Kostenlos starten →